{"id":"W2043370987","doi":"10.1038/ki.2008.629","title":"A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura","year":2009,"lang":"en","type":"review","venue":"Kidney International","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Hamilton Health Sciences; University Health Network; Canadian Apheresis Group; London Health Sciences Centre; McMaster University","funders":"","keywords":"Rituximab; Medicine; Thrombotic thrombocytopenic purpura; Immunosuppression; ADAMTS13; Immunology; Refractory (planetary science); Monoclonal antibody; Thrombocytopenic purpura; Von Willebrand factor; Antibody; Internal medicine; Platelet","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007963838,0.0003297309,0.000942264,0.000306855,0.0001648575,0.00002029207,0.001583022,0.0001022582,0.001052501],"category_scores_gemma":[0.0001518153,0.0001820255,0.0002287057,0.000283977,0.0001178789,0.00007026282,0.0001897054,0.0003691126,0.0000485646],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003748937,"about_ca_system_score_gemma":0.0007113664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002602057,"about_ca_topic_score_gemma":0.001631707,"domain_scores_codex":[0.9972005,0.0008135082,0.001022702,0.0003743561,0.0003079608,0.0002809339],"domain_scores_gemma":[0.9979607,0.0003345707,0.0008120188,0.0006893657,0.0001650645,0.00003821352],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007213004,0.04312525,0.00432778,0.004940485,0.01623606,0.00005794516,0.005177089,0.00001226581,0.000006940595,0.002513888,0.01732618,0.9055548],"study_design_scores_gemma":[0.04504947,0.009290141,0.04092059,0.02415164,0.006780372,0.00002938982,0.002051886,0.000005935713,0.00000192746,0.00009082056,0.8707843,0.0008434603],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1300573,0.8466229,0.00000520078,0.0005541383,0.00198024,0.01397549,0.002657402,0.00003209637,0.004115228],"genre_scores_gemma":[0.8759835,0.1180809,0.00006324346,0.0002253395,0.00007064165,0.0006639355,0.004304622,0.00006001326,0.0005477459],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9047114,"threshold_uncertainty_score":0.9998606,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05357560575945004,"score_gpt":0.3763391755558815,"score_spread":0.3227635697964315,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}